Pharma major Lupin Limited (Lupin) won the gold award at the 9th Annual Conference on Quality Management, organised by the American Society for Quality (ASQ) at Ahmedabad on 22 November, 2019. The nomination case study submitted for this award summarised the transformation project to improve the yield and quality of Lupin’s Cefadroxil products.

Speaking on the occasion, Rajendra B Chunodkar, President — Manufacturing Operations, Lupin Ltd. said, “It is a moment of pride. This is the fourth consecutive year that Lupin’s Ankleshwar facility has won the Gold Award from the American Society for Quality. As a leading pharmaceutical company, we have constantly focused our efforts towards enabling manufacturing excellence at all our manufacturing sites. This award highlights and validates our approach toward quality and continuous improvement.”

While, this year Lupin’s nomination highlighted the key outcomes of its “Cefadroxil Yield and Quality Improvement” project, in the past three years, Lupin won the award for projects that focused on Ethambutol Yield Improvement (2018), 7AE Yield Improvement (2017) and 7ACCA Yield Improvement (2016).

About ASQ

ASQ (American Society for Quality) is a knowledge-based global community of quality professionals who share the ideas and tools that make our world work better. With millions of individual and organizational members of the community in 150 countries, ASQ has the reputation and reach to bring together the diverse quality champions who are transforming the world’s corporations, organizations and communities to meet tomorrow’s critical challenges. ASQ is headquartered in Milwaukee, Wis., with national service centres in China, India and Mexico. Learn more about ASQ’s members, mission, technologies and training at www.asq.org.